From Optimism to Opportunity: Evolving Impacts of AI on Precision Medicine

From Optimism to Opportunity: Evolving Impacts of AI on Precision Medicine

The explosion of generative AI and, specifically, large language models (LLMs), has created renewed energy, focus and promise around the hype of AI impacting the R&D lifecycle. Generative AI is revolutionizing precision medicine clinical trial planning, execution, and operations. Organizations are increasingly recognizing its potential, rallying behind AI initiatives. The race is on – the race to leverage AI as a force multiplier, knowledge amplifier and value generator, ultimately accelerating time-to-insight. In this post, we explore concrete ways in which generative AI can deliver on these promises. Read More →
QuartzBio at Bio-IT World 2024 Recap and Recording

AI-Enabled Biomarker Intelligence — QuartzBio at Bio-IT World 2024

Discussions were lively at the “Digitization of Clinical Development & Clinical Trials” symposium at last week’s Bio-IT World conference. Addressing an audience of biotech and pharma IT and data leaders, QuartzBio’s Tobi Guennel gave a provocative presentation on how deploying generative AI can amplify the ability of precision medicine approaches to accelerate drug development. Read More →
QB_LinkedIn_SCOPE Presentation_Feb 2024

Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials

Tobi Guennel, PhD, QuartzBio’s Senior Vice President of Product & Chief Architect, energized the Biomarkers & Precision Medicine track at SCOPE 2024 by showing how generative AI can address challenges faced biospecimen and biomarker operations teams, as well as clinical and translational teams, when gathering insights on samples across all parts of a complex biomarker data ecosystem. Read More →
QuartzBio at SCOPE 2024

Join QuartzBio at SCOPE 2024 | Booth #300

Join QuartzBio at SCOPE 2024, the Summit for Clinical Operations Executives, at Booth 300. We'll be presenting “Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials” here you’ll learn about deploying generative AI in drug development. Read More →